Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Clinical Trials › Results
This page provides comprehensive data and analytics for recent trial results. Our database is updated regularly to ensure accuracy and relevance. Market conditions change rapidly, and staying informed is crucial for making sound decisions. This page aggregates the most relevant data points and presents them in an easily digestible format.
Historical data is available for trend analysis, allowing users to identify patterns and forecast future developments. The platform supports custom date ranges and filtering options for deeper analysis. Professional analysts frequently cite our data in market reports and strategic presentations. Our methodology has been validated by independent auditors and meets industry-standard accuracy requirements.
All data on FDA News is provided for informational purposes. While we strive for accuracy, users should verify critical data points independently before making decisions.
| Trial | Drug | Phase | Primary Endpoint | Result |
|---|---|---|---|---|
| BEACON-3 | ImmunoMax | Phase 3 | OS 18mo | Met (+4.2mo) |
| HEART-Plus | CardioVex | Phase 3 | MACE reduction | Met (-28%) |
| MIND-Clear | NeuroStar | Phase 2 | Cognitive score | Promising |
| BREATH-2 | PulmoNew | Phase 3 | FEV1 improve | Met (+180ml) |
| SKIN-Free | DermaPure | Phase 3 | PASI 90 | Met (62%) |
Data updated continuously. Last refresh: May 11, 2026 14:30 UTC.
